Gene signature discovery may predict response to immune therapy
Scientists led by Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have discovered a gene signature biomarker that may predict which patients will respond—or not—to immune therapy.
Nov 8, 2018
0
60